Aljian Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718K Buy
5,971
+22
+0.4% +$2.54K 0.15% 71
2025
Q4
$626K Buy
5,949
+33
+0.6% +$3.1K 0.12% 76
2025
Q3
$497K Sell
5,916
-31
-0.5% -$2.55K 0.1% 85
2025
Q2
$471K Sell
5,947
-193
-3% -$15.3K 0.1% 86
2025
Q1
$551K Buy
6,140
+141
+2% +$13.2K 0.13% 81
2024
Q4
$597K Sell
5,999
-118
-2% -$12.2K 0.13% 73
2024
Q3
$695K Buy
+6,117
New +$727K 0.16% 66

Other funds holding MRK

Aljian Capital Management's MRK Position: Q1 2026 in Review

Aljian Capital Management increased its Merck (MRK) stake by 0.37% in Q1 2026, buying an estimated $2.54K and bringing the position to 5,971 shares worth $718K. The position accounts for 0.15% of the portfolio, ranked #71.

Aljian Capital Management first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Aljian Capital Management held 5,971 shares of Merck worth $718K as of Q1 2026.
  • Aljian Capital Management bought 22 Merck shares in Q1 2026, an estimated $2.54K.
  • Merck made up 0.15% of Aljian Capital Management's portfolio in Q1 2026, its #71 holding.
  • Aljian Capital Management first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Aljian Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.